ASBIF's logo.
Ticker Symbol: ASBIF

ASIT biotech SA

Exchange: US OTC Country: BE Currency: USD Asset Type: Common Stock

Company Profile

ASIT BioTech SA is a clinical stage biopharmaceutical company, which engages in the research and development of immunotherapy treatments for environmental and food allergies. Its products include hdm-ASIT+, for the treatment of house dust mite allergy; and pnt-ASIT+for the treatment of peanut allergy. The company was founded by Thierry Legon in May 1997 and is headquartered in Liege, Belgium.

Sector: Health Technology
Industry: Biotechnology
Standard Industrial Classification Code (SIC code): 2836
Address: 7 Rue des Chasseurs Ardennais
CEO: Michel Baijot
  • Health Technology
  • Biotechnology


Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change: - ( 0.00%)
Days Range: - - -
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.00%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 21892592


Market Cap: -
PE Ratio: -
EPS (TTM): 0


Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A